<DOC>
	<DOCNO>NCT02752958</DOCNO>
	<brief_summary>This multicentre , non-comparative design study monitor impact long term management DH daily use sensitivity toothpaste quality life population sensitivity sufferer . Changes oral health relate quality life monitor use Dentine Hypersensitivity Experience Questionnaire ( DHEQ ) . The study conduct participant good general health , pre-existing self-reported clinically diagnose tooth sensitivity screening .</brief_summary>
	<brief_title>Impact Long Term Management Dentine Hypersensitivity ( DH ) With Daily Use Anti-sensitivity Toothpaste Quality Life Related Oral Health</brief_title>
	<detailed_description>This multicenter , non-comparative design monitor impact long term management DH daily use sensitivity toothpaste quality life population sensitivity sufferer , use DHEQ . Changes DH monitor clinically 24 week treatment period .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Dentin Sensitivity</mesh_term>
	<mesh_term>Tin Fluorides</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>Demonstrates understand study willingness participate evidence voluntary write informed consent receive sign date copy ofthe informed consent form Aged 1855 year Good general mental health , opinion investigator medically qualify designee : No clinically significant relevant abnormality medical history oral examination absence condition would impact participant 's safety wellbeing affect individual 's ability understand follow study procedures requirement Understands willing , able likely comply study procedure restriction At Visit 1 ( Screening ) : Selfreported dentinal hypersensitivity ( DH ) last six month 10 year , minimum 20 natural teeth , Minimum 2 accessible nonadjacent teeth ( incisor , canine , premolar ) , preferably different quadrant , meet follow criterion : Signs facial/cervical gingival recession and/or sign erosion abrasion ( EAR ) .Tooth MGI score =0 adjacent test area ( exposed dentine ) [ Lobene , 1986 ] clinical mobility ≤1 Tooth sign sensitivity measure qualify evaporative air assessment ( Y/N response ) At Visit 2 ( Baseline ) : Minimum two , nonadjacent accessible teeth ( incisor , canine , premolar ) , meet follow criterion : sign sensitivity , measure qualify evaporative air assessment ( Schiff Sensitivity Score ≥ 2 ) Women know pregnant intend become pregnant duration study Women breastfeed Known suspect intolerance hypersensitivity study material ( closely relate compound ) state ingredient Participation another clinical study ( include cosmetic study ) receipt investigational drug within 30 day screen visit . previous participation study Recent history ( within last year ) alcohol substance abuse An employee sponsor study site member immediate family Presence chronic debilitate disease , opinion investigator , could affect study outcome condition , opinion investigator , cause xerostomia Dental prophylaxis within 4 week Screening , tongue lip pierce presence dental implant , desensitize treatment within 8 week Screening ( professional sensitivity , treatment nondentifrice sensitivity treatment ) , gross periodontal disease , treatment periodontal disease ( include surgery ) within 12 month Screening , scale root planning within 3 month Screening teeth bleach within 8 week Screening Tooth evidence current recent caries , report treatment decay within 12 month Screening , tooth expose dentine deep , defective facial restoration , teeth use abutment fix removable partial denture , teeth full crown veneer , orthodontic band crack enamel . Sensitive teeth contribute aetiology erosion , abrasion recession expose dentine Sensitive tooth expect respond treatment overthecounter dentifrice opinion investigator Use oral care product indicated relief dentine hypersensitivity within 8 week screen ( participant require bring current oral care product site order verify absence know antisensitivity ingredient ) Daily dose medication/treatments , opinion investigator , could interfere perception pain . Examples medication include analgesic , anticonvulsant , antihistamine cause mark moderate sedation , sedative , tranquilizer , antidepressant , moodaltering antiinflammatory drug , currently take antibiotic take antibiotic within 2 week Baseline daily dose medication , opinion investigator , cause xerostomia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>